$ATXI

$0.54 -$0.03 (4.48%) Close

$ATXI Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 3.3M shares outstanding

Who owns ATXI?

By type of holder

Institutions 0.0% Insiders 96.1% Everyone else 3.9%

Concentration Top 3 holders own 59.5%

Herskowitz Neil 26.7% · Kranzler Jay D 19.4%

Institutional ownership

0.0%

0.0 pts vs last qtr

Institutional holders

0 vs last qtr

Net shares bought

by institutions in Q2 2026

New / sold out

0 / 0

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

None.

Biggest sellers in Q2 2026

None.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Avenue Therapeutics Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2021–FY2022

+92.8%

+92.84% a year

Each share's claim on the business

−48.1%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

$1.1M vs $1.09M

over 2 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

No 13F manager reports holding ATXI.

Super Investors

Investment managers reporting ATXI on Form 13F

No 13F manager reports holding ATXI yet.

Institutional Funds

Mutual funds and ETFs reporting ATXI on Form N-PORT; together they hold 0.3% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
FE Fidelity Extended Market Index Fund Fidelity Concord Street Trust	$7.17K	6.5K	0.20%	0.00%	February 28, 2025
FS Fidelity Series Total Market Index Fund Fidelity Concord Street Trust	$1.74K	1.6K	0.05%	0.00%	February 28, 2025

Fidelity Extended Market Index Fund

Fidelity Concord Street Trust

Position value

$7.17K

% of company

0.20%

% of the fund

0.00%

As of

February 28, 2025

Fidelity Series Total Market Index Fund

Fidelity Concord Street Trust

Position value

$1.74K

% of company

0.05%

% of the fund

0.00%

As of

February 28, 2025

2 more funds behind a free account

See every fund holding Avenue Therapeutics Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
HN Herskowitz Neil Insider	879.6K	26.70%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company26.700% Herskowitz Neil's insider activity →
KJ Kranzler Jay D Insider	640.0K	19.42%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company19.420% Kranzler Jay D's insider activity →

Herskowitz Neil

Insider

879.6K

% of company

26.70%

Change vs last qtr

—

Held since

—

Kranzler Jay D

Insider

640.0K

% of company

19.42%

Change vs last qtr

—

Held since

—

1 more holders behind a free account

See every insider and 5%+ holder of Avenue Therapeutics Inc.

Comments